ICU Medical (ICUI)

Nasdaq Health Care Health Care Supplies S&P SmallCap 600

$172.11

+4.46 (+2.66%)

Close of Nov 06, 2026 · end-of-day data

Source: ICU Medical's 10-K / 10-Q XBRL data on SEC EDGAR · fetched Nov 06, 2026

Revenue, net income & free cash flow

Income statement

fiscal years · USD

Fiscal year	FY2016	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
Revenue	$379.37M	$1.29B	$1.40B	$1.27B	$1.27B	$1.32B	$2.28B	$2.26B	$2.38B	$2.23B
Cost of revenue	$177.97M	$866.52M	$830.01M	$794.34M	$809.51M	$824.82M	$1.58B	$1.52B	$1.56B	$1.41B
Gross profit	$201.40M	$426.10M	$570.03M	$471.86M	$461.50M	$491.49M	$697.76M	$739.87M	$824.78M	$822.04M
Research & development	$12.96M	$51.25M	$52.87M	$48.61M	$42.95M	$47.50M	$92.98M	$85.34M	$88.61M	$87.50M
Selling, general & admin	$89.43M	$302.17M	$320.00M	$276.98M	$283.95M	$302.58M	$608.35M	$606.69M	$638.76M	$625.21M
Operating income	$82.94M	-$13.29M	$29.76M	$107.36M	$98.16M	$123.25M	-$42.90M	$22.82M	$42.96M	$42.83M
Interest expense	$118.00K	$2.05M	$709.00K	$549.00K	$1.75M	$858.00K	$70.81M	$102.73M	$106.54M	$93.34M
Pre-tax income	$85.16M	$51.28M	$22.37M	$114.71M	$97.49M	—	—	-$78.30M	-$66.01M	$4.36M
Income tax	$22.08M	-$17.36M	-$6.42M	$13.67M	$10.62M	$20.05M	-$40.12M	-$48.64M	$51.68M	$2.44M
Net income	$63.08M	$68.64M	$28.79M	$101.03M	$86.87M	$103.14M	-$74.29M	-$29.66M	-$117.69M	$732.00K
EBITDA	$101.99M	$53.27M	$104.49M	$184.28M	$183.79M	$212.94M	$192.25M	$251.60M	$262.48M	$243.57M
EPS (basic)	$3.90	$3.50	$1.41	$4.90	$4.16	$4.86	$-3.11	$-1.23	$-4.83	$0.03
EPS (diluted)	$3.66	$3.29	$1.33	$4.69	$4.02	$4.74	$-3.11	$-1.23	$-4.83	$0.03
Diluted shares	17.25M	20.86M	21.60M	21.55M	21.59M	21.78M	23.87M	24.09M	24.39M	24.90M
Gross margin	53.1%	33.0%	40.7%	37.3%	36.3%	37.3%	30.6%	32.8%	34.6%	36.8%
Operating margin	21.9%	-1.0%	2.1%	8.5%	7.7%	9.4%	-1.9%	1.0%	1.8%	1.9%
Net margin	16.6%	5.3%	2.1%	8.0%	6.8%	7.8%	-3.3%	-1.3%	-4.9%	0.0%

Balance sheet

fiscal years · USD

Fiscal year	FY2016	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
Cash & equivalents	$445.08M	$290.07M	$344.78M	$268.67M	$396.10M	$552.83M	$208.78M	$254.22M	$308.57M	$307.96M
Short-term investments	—	$10.06M	$37.33M	$23.97M	$14.69M	$14.42M	$4.22M	$501.00K	$0	—
Receivables	$56.16M	$112.70M	$176.30M	$202.22M	$124.09M	$105.89M	$221.72M	$161.57M	$182.83M	$180.51M
Inventory	$49.26M	$288.66M	$311.16M	$337.64M	$314.93M	$290.24M	$696.01M	$709.36M	$584.68M	$615.86M
Total current assets	$569.10M	$864.66M	$927.04M	$882.20M	$920.78M	$1.03B	$1.24B	$1.22B	$1.44B	$1.19B
Goodwill	$5.58M	$12.36M	$11.20M	$31.25M	$33.00M	$43.44M	$1.45B	$1.47B	$1.43B	$1.50B
Total assets	$704.69M	$1.50B	$1.59B	$1.69B	$1.76B	$1.88B	$4.52B	$4.38B	$4.20B	$4.05B
Total current liabilities	$40.54M	$210.29M	$249.29M	$248.47M	$195.49M	$200.78M	$494.56M	$481.84M	$556.18M	$498.86M
Short-term debt	—	—	—	$0	—	$0	$29.69M	$51.00M	$51.00M	$18.75M
Long-term debt	$0	—	—	—	—	$0	$1.62B	$1.58B	$1.53B	$1.27B
Total debt	$0	—	—	$0	—	$0	$1.65B	$1.63B	$1.58B	$1.28B
Total liabilities	$44.53M	$298.70M	$321.74M	$315.14M	$261.43M	$264.71M	$2.43B	$2.26B	$2.24B	$1.93B
Shareholders' equity	$660.15M	$1.20B	$1.26B	$1.38B	$1.50B	$1.62B	$2.09B	$2.12B	$1.97B	$2.12B

Cash flow

fiscal years · USD

Fiscal year	FY2016	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
Operating cash flow	$89.94M	$154.42M	$160.22M	$101.92M	$222.75M	$267.54M	-$62.13M	$166.20M	$204.03M	$179.85M
Capital expenditures	$23.36M	$74.48M	$92.72M	$97.31M	$92.00M	$68.54M	$90.31M	$83.89M	$79.37M	$88.04M
Free cash flow	$66.58M	$79.94M	$67.50M	$4.61M	$130.75M	$199.00M	-$152.44M	$82.31M	$124.66M	$91.80M
Investing cash flow	$16.28M	-$266.87M	-$103.37M	-$166.89M	-$98.14M	-$90.69M	-$1.91B	-$87.95M	-$88.96M	$122.23M
Financing cash flow	$2.47M	-$44.35M	$8.02M	-$10.91M	-$40.00K	-$16.87M	$1.64B	-$35.98M	-$55.80M	-$311.52M
Share buybacks	$17.23M	$4.06M	$6.25M	$18.64M	$12.88M	$8.34M	$10.88M	$9.35M	$11.99M	$8.77M
Stock-based compensation	$15.24M	$19.35M	$24.24M	$21.92M	$23.95M	$27.34M	$36.02M	$40.56M	$46.88M	$55.76M
Depreciation & amortization	$19.05M	$66.57M	$74.73M	$76.92M	$85.63M	$89.70M	$235.15M	$228.77M	$219.51M	$200.74M

Income statement

quarters · USD

Quarter ended	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026	Sep 2026
Revenue	$587.86M	$566.65M	$596.46M	$589.13M	$629.80M	$604.70M	$548.87M	$536.99M	$540.70M	$530.23M	$551.68M	$560.44M
Cost of revenue	—	$381.41M	$389.03M	$384.28M	—	$394.59M	$340.80M	$336.11M	—	$324.00M	$316.63M	$325.69M
Gross profit	$171.59M	$185.24M	$207.43M	$204.85M	$227.26M	$210.11M	$208.06M	$200.88M	$202.99M	$206.23M	$235.05M	$234.75M
Research & development	$22.41M	$21.84M	$23.39M	$21.03M	$22.36M	$23.29M	$21.87M	$21.25M	$21.09M	$21.28M	$22.70M	$21.75M
Selling, general & admin	$154.62M	$157.66M	$159.55M	$162.71M	$158.85M	$157.23M	$159.39M	$152.77M	$155.81M	$154.57M	$151.92M	$154.41M
Operating income	-$12.18M	-$10.65M	$7.69M	$8.24M	$37.69M	$12.89M	$10.59M	$13.72M	$5.63M	$13.58M	$39.13M	$52.32M
Interest expense	$31.92M	$23.77M	$23.84M	$24.68M	$34.24M	$22.03M	$20.55M	$19.81M	$30.95M	$16.49M	$15.75M	$15.24M
Pre-tax income	—	-$36.77M	-$19.53M	-$17.93M	—	-$10.91M	$33.68M	-$2.51M	—	-$3.98M	$23.14M	$36.18M
Income tax	-$19.53M	$2.70M	$1.87M	$15.05M	$32.05M	$4.57M	$1.18M	-$658.00K	-$2.65M	-$34.71M	$7.07M	$7.19M
Net income	—	-$39.47M	-$21.41M	-$32.98M	—	-$15.48M	$35.34M	-$3.40M	—	$30.13M	$19.09M	$26.85M
EBITDA	$44.98M	$44.87M	$63.01M	$63.91M	$90.68M	$62.33M	$60.25M	$64.52M	$56.46M	$63.61M	$88.74M	$101.92M
EPS (basic)	$-0.71	$-1.63	$-0.88	$-1.35	$-0.98	$-0.63	$1.43	$-0.14	$-0.64	$1.22	$0.76	$1.07
EPS (diluted)	$-0.71	$-1.63	$-0.88	$-1.35	$-0.98	$-0.63	$1.43	$-0.14	$-0.63	$1.20	$0.76	$1.07
Diluted shares	16.00K	24.22M	24.39M	24.44M	35.00K	24.54M	24.71M	24.69M	121.00K	25.18M	25.04M	25.14M
Gross margin	29.2%	32.7%	34.8%	34.8%	36.1%	34.7%	37.9%	37.4%	37.5%	38.9%	42.6%	41.9%
Operating margin	-2.1%	-1.9%	1.3%	1.4%	6.0%	2.1%	1.9%	2.6%	1.0%	2.6%	7.1%	9.3%
Net margin	—	-7.0%	-3.6%	-5.6%	—	-2.6%	6.4%	-0.6%	—	5.7%	3.5%	4.8%

Balance sheet

quarters · USD

Quarter ended	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026	Sep 2026
Cash & equivalents	$254.22M	$251.42M	$302.65M	$312.51M	$308.57M	$289.70M	$300.02M	$299.73M	$307.96M	$288.33M	$298.30M	$301.78M
Short-term investments	$501.00K	$0	$0	$0	$0	—	—	—	—	—	—	—
Receivables	$161.57M	$145.19M	$151.76M	$173.98M	$182.83M	$170.93M	$179.50M	$191.54M	$180.51M	$201.08M	$183.53M	$206.26M
Inventory	$709.36M	$693.01M	$682.87M	$692.04M	$584.68M	$590.33M	$616.47M	$622.44M	$615.86M	$605.59M	$607.42M	$607.27M
Total current assets	$1.22B	$1.19B	$1.24B	$1.26B	$1.44B	$1.42B	$1.18B	$1.21B	$1.19B	$1.21B	$1.21B	$1.22B
Goodwill	$1.47B	$1.46B	$1.45B	$1.48B	$1.43B	$1.46B	$1.50B	$1.50B	$1.50B	$1.49B	$1.48B	$1.48B
Total assets	$4.38B	$4.29B	$4.29B	$4.31B	$4.20B	$4.18B	$4.11B	$4.10B	$4.05B	$4.01B	$3.97B	$3.94B
Total current liabilities	$481.84M	$455.36M	$511.91M	$549.56M	$556.18M	$549.02M	$482.78M	$492.90M	$498.86M	$517.90M	$498.36M	$514.63M
Short-term debt	$51.00M	$51.00M	$51.00M	$51.00M	$51.00M	$47.81M	$0	$0	$18.75M	$18.75M	$18.75M	$18.75M
Long-term debt	$1.58B	$1.57B	$1.55B	$1.54B	$1.53B	$1.49B	$1.34B	$1.31B	$1.27B	$1.26B	$1.21B	$1.13B
Total debt	$1.63B	$1.62B	$1.61B	$1.59B	$1.58B	$1.54B	$1.34B	$1.31B	$1.28B	$1.28B	$1.23B	$1.15B
Total liabilities	$2.26B	$2.22B	$2.25B	$2.26B	$2.24B	$2.20B	$1.99B	$1.98B	$1.93B	$1.90B	$1.82B	$1.75B
Shareholders' equity	$2.12B	$2.07B	$2.04B	$2.05B	$1.97B	$1.99B	$2.12B	$2.13B	$2.12B	$2.11B	$2.15B	$2.19B

Cash flow

quarters · USD

Quarter ended	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026	Sep 2026
Operating cash flow	$91.27M	$45.79M	$81.95M	$36.10M	$40.19M	$51.33M	$11.21M	$56.71M	$60.60M	$38.91M	$80.15M	$99.59M
Capital expenditures	$29.94M	$15.91M	$19.47M	$19.91M	$24.08M	$14.62M	$19.70M	$29.08M	$24.65M	$11.30M	$18.51M	$16.19M
Free cash flow	$61.33M	$29.88M	$62.49M	$16.19M	$16.11M	$36.71M	-$8.48M	$27.63M	$35.95M	$27.61M	$61.64M	$83.40M
Investing cash flow	-$30.65M	-$17.86M	-$21.69M	-$22.86M	-$26.55M	-$16.81M	$187.46M	-$30.03M	-$18.39M	-$11.21M	-$20.14M	-$13.93M
Financing cash flow	-$7.85M	-$26.84M	-$10.38M	-$10.38M	-$8.19M	-$56.34M	-$195.01M	-$25.69M	-$34.48M	-$44.12M	-$50.23M	-$80.97M
Stock-based compensation	$10.69M	$11.60M	$11.00M	$11.77M	$12.52M	$12.18M	$14.46M	$15.24M	$13.88M	$14.01M	$11.87M	$11.86M
Depreciation & amortization	$57.16M	$55.53M	$55.32M	$55.67M	$52.99M	$49.45M	$49.66M	$50.80M	$50.83M	$50.03M	$49.61M	$49.59M

Quarterly figures are rebuilt from the year-to-date totals companies report — Q4 is the full year minus the first nine months, since no 10-Q is filed for it. Values are as filed; later restatements replace earlier ones. Fiscal years are labelled by the calendar year in which they end.